Pharmacokinetics of selective estrogen receptor modulators (SERMs).
M Terauchi - Clinical Calcium, 2016 - europepmc.org
Clinical Calcium, 2016•europepmc.org
Selective estrogen receptor modulators (SERMs), or estrogen receptor agonists/antagonists
(ERAAs), are a class of compounds that function as estrogen receptor (ER) agonists or
antagonists tissue-dependently. Two types of SERMs are currently used in Japan to treat
osteoporosis, raloxifene (RLX: Evista) and bazedoxifene (BZA: Viviant). This article
describes the pharmacokinetics of these two drugs.
(ERAAs), are a class of compounds that function as estrogen receptor (ER) agonists or
antagonists tissue-dependently. Two types of SERMs are currently used in Japan to treat
osteoporosis, raloxifene (RLX: Evista) and bazedoxifene (BZA: Viviant). This article
describes the pharmacokinetics of these two drugs.
Selective estrogen receptor modulators (SERMs), or estrogen receptor agonists/antagonists (ERAAs), are a class of compounds that function as estrogen receptor (ER) agonists or antagonists tissue-dependently. Two types of SERMs are currently used in Japan to treat osteoporosis, raloxifene (RLX: Evista) and bazedoxifene (BZA: Viviant). This article describes the pharmacokinetics of these two drugs.
europepmc.org